Speaker illustration

Doctor Uugantsetseg Munkhjargal

University of Tokushima, Tokushima (Japan)

A selective mineralocorticoid receptor blocker, esaxerenone, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein e-deficient mice

Event: ESC Congress 2023

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session: Atherosclerosis

Thumbnail

ESC 365 is supported by